The company, Evaluate Diagnostics, will offer tests that identify disease biomarkers for the early detection of tumors and other diseases.
The diagnostic assays use technology developed at the Hackensack Meridian Health Research Institute. Hackensack Meridian’s Office of Innovation and Commercialization is aiding in the company’s launch.
Learn more here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
